Figure 2
Mean platelet count in all patients treated at the ixazomib MTD of 2.97 mg/m2. Thrombocytopenia appeared transient and cyclical, with recovery of platelet count toward baseline in the rest period at the end of each treatment cycle.
Mean platelet count in all patients treated at the ixazomib MTD of 2.97 mg/m2. Thrombocytopenia appeared transient and cyclical, with recovery of platelet count toward baseline in the rest period at the end of each treatment cycle.
